Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $1.57 Million - $1.79 Million
20,697 New
20,697 $1.6 Million
Q3 2020

Nov 16, 2020

SELL
$62.1 - $78.08 $915,478 - $1.15 Million
-14,742 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $1.07 Million - $1.24 Million
14,742 New
14,742 $1.13 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $4.88 Million - $6.25 Million
-77,956 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$61.62 - $67.78 $10,845 - $11,929
-176 Reduced 0.23%
77,956 $5.07 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $661,730 - $730,434
10,586 Added 15.67%
78,132 $4.95 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $61 - $69
1 Added 0.0%
67,546 $4.56 Million
Q1 2019

May 16, 2019

SELL
$62.53 - $70.05 $331,221 - $371,054
-5,297 Reduced 7.27%
67,545 $4.39 Million
Q4 2018

Feb 14, 2019

BUY
$60.54 - $79.0 $234,229 - $305,651
3,869 Added 5.61%
72,842 $4.56 Million
Q3 2018

Nov 15, 2018

SELL
$71.28 - $78.92 $245,844 - $272,195
-3,449 Reduced 4.76%
68,973 $5.33 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $529,226 - $617,321
8,157 Added 12.69%
72,422 $5.13 Million
Q1 2018

May 16, 2018

SELL
$72.84 - $88.8 $9.11 Million - $11.1 Million
-125,098 Reduced 66.06%
64,265 $4.85 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $9.57 Million - $11.2 Million
134,468 Added 244.95%
189,363 $13.6 Million
Q3 2017

Nov 07, 2017

BUY
$72.11 - $85.47 $3.96 Million - $4.69 Million
54,895
54,895 $4.45 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.